3002.13.00.10/Bevacizumab Monoclonal Antibody/Mexico

Bevacizumab Monoclonal Antibody from Mexico

Bevacizumab (Avastin) is a humanized monoclonal antibody binding VEGF, used for colorectal and lung cancer treatments. HTS 3002.13.0010 covers this unmixed, biotech-produced immunological product not in retail packaging. It qualifies as a protein regulating immunological processes per chapter definitions.

Duty Rate — Mexico → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Include potency assay results (e.g

• VEGF binding) in documentation for CBP review

• For EU-origin, leverage mutual recognition agreements to streamline FDA pre-approval